Cases & Deals

Turnstone Biologics develops patent portfolios for its oncolytic virus platforms

Clients Turnstone Biologics Corp.

Jones Day is representing Turnstone Biologics Corp. in the development of its oncolytic virus platforms.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.